![Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis – The PRECISION Trial | Cardiology Now Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis – The PRECISION Trial | Cardiology Now](http://cardiologynownews.org/wp-content/uploads/2018/04/PRECISION-trial.jpg)
Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis – The PRECISION Trial | Cardiology Now
![Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/0174af37-6db2-4b29-924c-843fcdc2712f/fx1.jpg)
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology
![Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective - Harvard Health Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective - Harvard Health](https://domf5oio6qrcr.cloudfront.net/medialibrary/9026/iStock-140279061.jpg)
Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective - Harvard Health
![Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial - The Lancet Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/f897a86b-51ec-469d-937e-c1560a13fb9b/gr1.gif)